All 258 BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Holdings
There are 258 BIB holdings. Top 10 companies weight: 60.91%.
Total Market Cap: $1.73T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (258 stocks) | +18.25% | 21.12 | 15.77 | 0.45 | +26.32% | +9.60% | 0.75 | ||||||||||
201 | SLN | Silence Therapeutics Plc Adr | 0.02% | $10.85 | $494M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +168.85% | $29 | -16.00% | 0.91 |
202 | SGMT | N/A | 0.02% | $7.07 | $181M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +270.58% | $26 | 0.00% | 1.87 |
203 | PBYI | Puma Biotechnology Inc | 0.02% | $8.58 | $428M | Biotechnology | Healthcare | N/A | 17.32 | 3.46 | 0.03 | N/A | N/A | 50 | -41.72% | $5 | +1.33% | 0.78 |
204 | PACB | Pacific Biosciences Of California Inc | 0.02% | $1.40 | $475M | Medical Devices | Healthcare | +5.07% | N/A | N/A | N/A | N/A | N/A | 57 | +75.57% | $2.46 | -46.30% | 1.95 |
205 | PRTA | Prothena Corp Plc | 0.02% | $8.75 | $447M | Biotechnology | Healthcare | -1.54% | N/A | 10.63 | N/A | N/A | N/A | N/A | +144.57% | $21 | -29.80% | 0.89 |
206 | NGNE | Neurogene Inc | 0.02% | $36.68 | $616M | Biotechnology | Healthcare | +11.24% | N/A | N/A | N/A | N/A | N/A | 75 | +122.76% | $82 | -25.83% | 1.87 |
207 | EDIT | Editas Medicine Inc | 0.02% | $2.89 | $349M | Biotechnology | Healthcare | -10.67% | N/A | N/A | N/A | N/A | N/A | 55 | +100.00% | $5.78 | -41.73% | 2.15 |
208 | ENTA | Enanta Pharmaceuticals Inc | 0.02% | $13.42 | $384M | Biotechnology | Healthcare | +8.56% | N/A | 44.05 | N/A | N/A | N/A | 75 | +57.75% | $21 | -20.03% | 0.94 |
209 | CCCC | C4 Therapeutics Inc Ordinary Shares | 0.02% | $3.83 | $395M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +248.04% | $13 | -37.47% | 1.76 |
210 | CTNM | N/A | 0.02% | $13.90 | $546M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +60.65% | $22 | 0.00% | 0.76 |
211 | ALT | Altimmune Inc | 0.02% | $2.82 | $374M | Biotechnology | Healthcare | -10.93% | N/A | 8.18 | 32.62 | N/A | N/A | 75 | +447.87% | $15 | -21.15% | 1.53 |
212 | KYTX | Kyverna Therapeutics Inc | 0.02% | $7.48 | $471M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +306.42% | $30 | 0.00% | 1.78 |
213 | TECX | Tectonic Therapeutic Inc | 0.02% | $32.80 | $612M | Biotechnology | Healthcare | -34.69% | N/A | N/A | N/A | N/A | N/A | 77 | +139.15% | $78 | -18.84% | 1.61 |
214 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 0.02% | $20.48 | $2.27B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +62.60% | $33 | -33.79% | 0.91 |
215 | n/a | Kamada Ltd | 0.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
216 | LKFT | Lakefront Biotherapeutics Nv Adr | 0.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
217 | UPB | Upstream Bio Inc | 0.02% | $6.98 | $396M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +447.99% | $38 | 0.00% | 1.09 |
218 | AQST | Aquestive Therapeutics Inc | 0.02% | $4.04 | $491M | Drug Manufacturers - Specialty & Generic | Healthcare | -17.65% | N/A | N/A | N/A | N/A | N/A | 80 | +120.05% | $8.89 | +1.45% | 1.37 |
219 | VYGR | Voyager Therapeutics Inc | 0.01% | $3.14 | $193M | Biotechnology | Healthcare | N/A | N/A | 8.44 | N/A | N/A | N/A | 75 | +374.20% | $15 | -0.99% | 1.41 |
220 | AVXL | Anavex Life Sciences Corp | 0.01% | $2.56 | $232M | Biotechnology | Healthcare | +0.72% | N/A | 3.85 | N/A | N/A | N/A | N/A | N/A | N/A | -35.18% | N/A |
221 | ACIU | Ac Immune Sa | 0.01% | $2.30 | $233M | Biotechnology | Healthcare | -4.76% | N/A | 11.24 | N/A | N/A | N/A | 75 | +269.13% | $8.49 | -20.99% | 1.04 |
222 | ARCT | Arcturus Therapeutics Holdings Inc | 0.01% | $5.99 | $182M | Biotechnology | Healthcare | -9.76% | N/A | 2.48 | N/A | N/A | N/A | 70 | +243.91% | $21 | -28.25% | 1.65 |
223 | VNDA | Vanda Pharmaceuticals Inc | 0.01% | $5.48 | $352M | Biotechnology | Healthcare | N/A | N/A | 103.09 | N/A | N/A | N/A | 68 | +157.66% | $14 | -22.35% | 0.64 |
224 | TKNO | Alpha Teknova Inc | 0.01% | $5.34 | $284M | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +68.54% | $9 | -21.51% | 1.59 |
225 | LENZ | Lenz Therapeutics Inc | 0.01% | $5.16 | $156M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +520.16% | $32 | -47.20% | 1.54 |
226 | LXEO | Lexeo Therapeutics Inc | 0.01% | $4.66 | $351M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +348.28% | $21 | 0.00% | 1.99 |
227 | CRBU | Caribou Biosciences Inc Ordinary Shares | 0.01% | $1.65 | $168M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +627.27% | $12 | 0.00% | 1.85 |
228 | AVIR | Atea Pharmaceuticals Inc Ordinary Shares | 0.01% | $4.87 | $389M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +78.03% | $8.67 | -28.20% | 0.74 |
229 | CHRS | Coherus Oncology Inc | 0.01% | $1.47 | $222M | Biotechnology | Healthcare | N/A | 0.85 | 41.15 | N/A | N/A | N/A | 75 | +430.61% | $7.80 | -35.01% | 1.60 |
230 | NMRA | Neumora Therapeutics Inc | 0.01% | $1.62 | $293M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | +288.85% | $6.28 | 0.00% | 1.20 |
231 | KROS | Keros Therapeutics Inc | 0.01% | $10.57 | $218M | Biotechnology | Healthcare | +7.98% | N/A | 48.78 | N/A | N/A | N/A | 60 | +106.53% | $22 | -22.54% | 0.59 |
232 | LRMR | Larimar Therapeutics Inc | 0.01% | $3.93 | $396M | Biotechnology | Healthcare | -8.46% | N/A | N/A | N/A | N/A | N/A | 80 | +266.41% | $14 | -17.00% | 1.56 |
233 | LYEL | Lyell Immunopharma Inc Ordinary Shares | 0.01% | $13.11 | $333M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +183.52% | $37 | -46.93% | 1.46 |
234 | LFCR | Lifecore Biomedical Inc | 0.01% | $4.64 | $182M | Drug Manufacturers - Specialty & Generic | Healthcare | +16.09% | N/A | 8.67 | N/A | N/A | N/A | 70 | +47.20% | $6.83 | -16.40% | 1.55 |
235 | IVVD | Invivyd Inc Ordinary Shares | 0.01% | $0.68 | $231M | Biotechnology | Healthcare | N/A | N/A | 44.64 | N/A | N/A | N/A | 75 | +1366.92% | $10 | 0.00% | 1.32 |
236 | IMRX | Immuneering Corp Class A | 0.01% | $4.46 | $334M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +300.45% | $18 | 0.00% | 0.90 |
237 | FULC | Fulcrum Therapeutics Inc | 0.01% | $3.68 | $237M | Biotechnology | Healthcare | -12.14% | N/A | N/A | N/A | N/A | N/A | 31 | +58.42% | $5.83 | -15.30% | 1.19 |
238 | HUMA | Humacyte Inc | 0.01% | $0.67 | $151M | Biotechnology | Healthcare | N/A | N/A | 35.84 | N/A | N/A | N/A | 75 | +205.61% | $2.05 | 0.00% | 2.47 |
239 | MENS | Jyong Biotech Ltd | 0.01% | $2.58 | $174M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | 2.33 |
240 | TNYA | Tenaya Therapeutics Inc | 0.01% | $0.82 | $183M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 81 | +385.08% | $4 | 0.00% | 1.96 |
241 | OBIO | Orchestra Biomed Holdings Inc | 0.01% | $3.69 | $214M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +229.81% | $12 | -17.90% | 1.64 |
242 | QSI | Quantum-si Inc Ordinary Shares Class A | 0.01% | $0.84 | $187M | Medical Devices | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +199.04% | $2.50 | -41.27% | 2.36 |
243 | SIGA | Siga Technologies Inc | 0.01% | $3.58 | $255M | Drug Manufacturers - Specialty & Generic | Healthcare | -17.22% | 12.57 | 24.57 | 3.37 | N/A | N/A | N/A | +389.66% | $18 | -2.51% | 0.78 |
244 | CDXS | Codexis Inc | 0.01% | $2.20 | $201M | Biotechnology | Healthcare | -2.98% | N/A | 149.25 | 13.53 | N/A | N/A | 71 | +199.09% | $6.58 | -36.44% | 1.82 |
245 | AUTL | Autolus Therapeutics Plc Adr | 0.01% | $1.47 | $402M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +483.62% | $8.55 | -24.39% | 1.28 |
246 | TRDA | Entrada Therapeutics Inc | 0.01% | $6.46 | $276M | Biotechnology | Healthcare | N/A | N/A | 3333.33 | N/A | N/A | N/A | 71 | +190.25% | $19 | 0.00% | 1.41 |
247 | PYXS | Pyxis Oncology Inc | 0.01% | $2.23 | $153M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +202.69% | $6.75 | 0.00% | 1.37 |
248 | OABI | Omniab Inc | 0.01% | $2.09 | $301M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +250.72% | $7.33 | 0.00% | 1.08 |
249 | NBP | Novabridge Biosciences Adr | 0.01% | $1.83 | $149M | Biotechnology | Healthcare | N/A | N/A | 2.68 | N/A | N/A | N/A | 75 | +337.16% | $8 | -52.78% | 0.91 |
250 | FHTX | Foghorn Therapeutics Inc Ordinary Shares | 0.01% | $5.16 | $320M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +121.71% | $11 | -11.79% | 1.78 |
BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Sector Allocation
HEALTHCARE
53.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%